Innovation in Mitochondrial Therapeutics: Pharmaceuticals, Phytochemicals and Nutritional Strategies
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Mitochondria".
Deadline for manuscript submissions: closed (15 February 2019) | Viewed by 460
Special Issue Editor
Interests: bioenergetics; targeting mitochondria in cancer; mitochondrial modulation and medicine; REDOX signaling; metabolic reprogramming
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are launching a Special Issue on mitochondrial drugs given the strong interest in the therapeutic modulation of organelle functions in a large number of human diseases. The pharmaceutical and biotechnology sectors have discovered new compounds able to modulate respiratory chain function and intermediate metabolism with impact on various cell features ranging from migration, differentiation, immune-reactivity or aging. There is a tremendous unmet need for the discovery of medicine acting on the mitochondrion and recent efforts brought new and repurposed molecules to the clinical trial stage. The time has come to give an overview on mitochondrial drug research and to discuss strength and weaknesses, efficacy and toxicity, mechanism of action and resistance, linked with the different approaches. Mitochondrial drugs have implications for the treatment of cancer, rare diseases, metabolic diseases, neurodegenerative disorders and infections so that research at the frontier of these disciplines has emerged in the recent years. In this Special Issue we foster the participation of specialists from both academia and industry to strengthen the translatability of mitochondrial drug discovery.
Dr. Rodrigue Rossignol
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mitochondria
- energy metabolism
- drug
- tool compound
- drug screening
- drug discovery
- drug repurposing
- clinical trial
- preclinical studies
- toxicity
- mode of action
- bioenergetics
- age-related diseases
- rare diseases
- metabolic diseases
- chemoresistance
- Immunology
- oxidative stress
- aging
